Dr. Lainwala is the director of the regional neonatal neurodevelopmental follow-up program at Connecticut Children’s. She is also the founder and chair of the NICU nutritional care and research group. Dr. Lainwala is actively involved in initiatives in the NICU to improve the nutrition and growth of preterm infants. Her research interests include studying nutrition and growth of preterm infants in the NICU and the long-term growth and developmental outcomes of preterm and sick infants.


Grant Medical College, INDIA


Maimonides Medical Center


Tufts New England Medical Center

American Board of Pediatrics - Neonatal-Perinatal Medicine
American Board of Pediatrics - Pediatrics

Associate Professor of Pediatrics, University of Connecticut School of Medicine

  • Lainwala S, Kosyakova N, Spizzoucco AM, Herson V, and Brownell EA. Clinical and nutritional outcomes of two liquid human milk fortifiers used in preterm infants. Journal of Neonatal Perinatal Medicine. Accepted July 2017.
  • Lainwala S, and Hussain N. Treatment of patent ductus arteriosus with cylco-oxygenase inhibitors beyond 2 weeks of age in very low birth weight infants. American Journal of Perinatology 33:584-589. 2016.